Sitagliptin Accelerates Endothelial Regeneration after Vascular Injury Independent from GLP1 Receptor Signaling
Introduction. DPP4 inhibitors (gliptins) are commonly used antidiabetic drugs for the treatment of type 2 diabetes. Gliptins also act in a glucose-independent manner and show vasoregenerative effects. We have shown that gliptins can remarkably accelerate vascular healing after vascular injury. Howev...
Saved in:
Main Authors: | Friederike Remm (Author), Nicolle Kränkel (Author), Daniela Lener (Author), Daniel J. Drucker (Author), Sieghart Sopper (Author), Christoph Brenner (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2018-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Optimized Stem Cell Detection Using the DyeCycle-Triggered Side Population Phenotype
by: Maximilian Boesch, et al.
Published: (2016) -
GLP-1 physiology informs the pharmacotherapy of obesity
by: Daniel J. Drucker
Published: (2022) -
A Physiologically‐Based Quantitative Systems Pharmacology Model of the Incretin Hormones GLP‐1 and GIP and the DPP4 Inhibitor Sitagliptin
by: Pavel Balazki, et al.
Published: (2020) -
Endothelial-Dependent and Independent Vascular Relaxation Effect of Tetrahydropalmatine on Rat Aorta
by: Zhong-Yan Zhou, et al.
Published: (2019) -
Glucagon-like peptide-2 promotes gallbladder refilling via a TGR5-independent, GLP-2R-dependent pathway
by: Bernardo Yusta, et al.
Published: (2017)